Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Invitrogen™ CD102 (ICAM-2) Monoclonal Antibody (3C4), Biotin

Rat Monoclonal Antibody

Supplier:  Invitrogen™ MA528663

Catalog No. PIMA528663


Only null left
Add to Cart

Description

Description

CD102 (ICAM-2) Monoclonal Antibody for Flow

ICAM-2 is a member of the intercellular adhesion molecule (ICAM) family. All ICAM proteins are type I transmembrane glycoproteins, contain 2-9 immunoglobulin-like C2-type domains, and bind to the leukocyte adhesion LFA-1 protein. ICAM-2 may play a role in lymphocyte recirculation by blocking LFA-1-dependent cell adhesion. It mediates adhesive interactions important for antigen-specific immune response, NK-cell mediated clearance, lymphocyte recirculation, and other cellular interactions important for immune response and surveillance. Several transcript variants encoding the same protein have been found for this gene. Diseases associated with ICAM2 include Colon Carcinoma In Situ.
TRUSTED_SUSTAINABILITY
Specifications

Specifications

CD102 (ICAM-2)
Monoclonal
0.5 mg/mL
PBS with <0.1% sodium azide; pH 7.4
P35330
ICAM2
COS cells transfected with mouse ICAM-2 cDNA and BW5147 AKR/J mouse thymoma cell line.
1 mL
Primary
Mouse
Antibody
IgG2a κ
Flow Cytometry
3C4
Biotin
ICAM2
CD102; Icam2; ICAM-2; Intercellular adhesion molecule 2; Ly-60; Lymphocyte function-associated AG-1 counter-receptor; RP23-418O11.10-001
Rat
Purified
RUO
15896
4°C
Liquid
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Product Certifications
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.